CN1238001C - Medicine for treating diseases of liver, gallbladder and spleen - Google Patents
Medicine for treating diseases of liver, gallbladder and spleen Download PDFInfo
- Publication number
- CN1238001C CN1238001C CN 02110418 CN02110418A CN1238001C CN 1238001 C CN1238001 C CN 1238001C CN 02110418 CN02110418 CN 02110418 CN 02110418 A CN02110418 A CN 02110418A CN 1238001 C CN1238001 C CN 1238001C
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- grams
- gallbladder
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a medicine for treating diseases of the liver, gallbladder and spleen, which is prepared from the medical components by proportioning weight: 100 to 150 of white paeony root, 3 to 10 of bupleurum root, 30 to 50 of licorice root, 3 to 10 of olibanum, 3 to 10 of aucklandia root, 15 to 60 of white mustard seed, 6 to 10 of peach kernel, 20 to 80 of rehmannia root, 1 to 6 of fructus, 10 to 80 of angelica, 1 to 6 of chuanxiong rhizome, 5 to 15 of cape jasmine fruit, 30 to 80 of milk vetch and 10 to 20 of pilose asiabell root. After being decocted by water, the medical components can be prepared into oral medicinal liquid; after being concentrated, the decoction liquid can be prepared into pills, medicinal powder, etc. The medicine is prepared from pure traditional Chinese medicines, and has the advantages of particular, scientific and reasonable material selection, no toxic or side effect, convenient administration, favorable treatment effect, rapid therapeutic effect, stable medicine effect, stabilization and reliability for treating diseases of the liver, gallbladder and spleen and low racurrence rate; the autoimmunity of cured patients is raised, and the present invention particularly has specific effect on treating gallbladder diseases.
Description
Technical field
The invention belongs to technical field of pharmaceuticals, be a kind of medicine for the treatment of liver, gallbladder, splenic disease, especially the treatment gallbladder disease is had specially good effect.
Background technology
Chinese medicine takes stopgap measures and effects a permanent cure, and has no side effect, and rather people accept and select for use, and Chinese medicine has been widely used in treating multiple disease, and is respond well.
At present, liver, gallbladder, splenic disease, especially gallbladder disease are a kind of obstinate diseases, and sickness rate is higher, and treatment is also difficult.Though some medicines have certain curative effect, life-time service can have infringement to internal organs, as for the gallbladder disease patient, takes anti-inflammatory and choleretic class medicine for a long time in a large number, and the as easy as rolling off a log hypercholia that causes of meeting causes liver, spleen complication, so that aggravates disease.The state of an illness is shown effect repeatedly, and delay is difficult, and misery has very increased patient's financial burden weight again.Up to now, there is not to find to have the specific drug of treatment liver, gallbladder, splenic disease.
Summary of the invention
Technical problem to be solved by this invention is: provide that a kind of therapeutic effect is good, curative effect is fast, efficacy stability, relapse rate are low, can improve patient more treatment liver, gallbladder, the medicine of splenic disease of back autoimmunity, especially the treatment gallbladder disease is had specially good effect.
The medicine of treatment liver of the present invention, gallbladder, splenic disease, form by weight by following active component:
100～150 parts of the Radix Paeoniae Albas, 3～10 parts of Radix Bupleuri, 30～50 parts in Radix Glycyrrhizae, 3～10 parts of Olibanums, 3～10 parts of the Radix Aucklandiae, 15～60 parts of Semen Sinapis Albaes, 6～10 parts in Semen Persicae, 20～80 parts in the Radix Rehmanniae, 1～6 part of Fructus Aurantii, 10～80 parts of Radix Angelicae Sinensis, 1～6 part of Rhizoma Chuanxiong, 5～15 parts of Fructus Gardeniaes, 30～80 parts of the Radixs Astragali, 10～20 parts of Radix Codonopsis.
Best compositing range is:
110～140 parts of the Radix Paeoniae Albas, 4～8 parts of Radix Bupleuri, 40～50 parts in Radix Glycyrrhizae, 4～8 parts of Olibanums, 4～8 parts of the Radix Aucklandiae, 25～45 parts of Semen Sinapis Albaes, 6～10 parts in Semen Persicae, 40～70 parts in the Radix Rehmanniae, 3～6 parts of Fructus Aurantiis, 40～60 parts of Radix Angelicae Sinensis, 2～5 parts of Rhizoma Chuanxiongs, 8～12 parts of Fructus Gardeniaes, 40～70 parts of the Radixs Astragali, 10～20 parts of Radix Codonopsis.
Best group becomes:
120 parts of the Radix Paeoniae Albas, 5 parts of Radix Bupleuri, 50 parts in Radix Glycyrrhizae, 5 parts of Olibanums, 5 parts of the Radix Aucklandiae, 30 parts of Semen Sinapis Albaes, 8 parts in Semen Persicae, 60 parts in the Radix Rehmanniae, 5 parts of Fructus Aurantiis, 50 parts of Radix Angelicae Sinensis, 3 parts of Rhizoma Chuanxiongs, 10 parts of Fructus Gardeniaes, 50 parts of the Radixs Astragali, 15 parts of Radix Codonopsis.
Using method is mixed medicine part and is made oral liquid behind the decocting and take preferably, make pill, powder etc. after also can medicine part is refining purifying, and during decocting, preferably the Olibanum and the Radix Aucklandiae is pulverized earlier, is convenient to oozing out, leaching of effective ingredient, to guarantee the better drug effect of acquisition.Avoid cold and uncooked food when taking, pungent, greasy.Unaccomplished matter requires to get final product with reference to the Chinese medicine routine operation.
Medicine of the present invention is reused the Radix Paeoniae Alba in forming, and Radix Paeoniae Alba consumption is big, doubly to ordinary, to improve the power of suppressing the hyperactive liver, function of gallbladder promoting; Radix Angelicae Sinensis, Rhizoma Chuanxiong, Semen Persicae be tonifying liver blood both, the liver blood of living again; Fructus Gardeniae, the Radix Rehmanniae reduce internal heat with removing heat from blood; Radix Bupleuri, Radix Glycyrrhizae, the Radix Paeoniae Alba, Olibanum, the Radix Aucklandiae, Fructus Aurantii, suppressing the hyperactive liver function of gallbladder promoting, relieving spasm to stop pain; Semen Persicae, Semen Sinapis Albae eliminate the phlegm and lose the stasis of blood; The Radix Astragali, Radix Codonopsis complement are set upright.What particularly point out is both suppressing the hyperactive liver function of gallbladder promoting of the Radix Paeoniae Alba, Fructus Gardeniae, Rhizoma Chuanxiong three medicine parts, can impel bile speed to give birth to again rapidly, and the gallbladder of atrophy is filled at short notice.Each component interaction of medicine of the present invention, play special effect altogether, blood circulation promoting and blood stasis dispelling not only, eliminating stagnation relieves the pain, the suppressing the hyperactive liver function of gallbladder promoting, and impel the rapid hair growth promoting of bile, recover gallbladder form and function, recovering, the back is difficult recurs, and more crucial is to regulate the function of exempting from service that improves the liver and gall spleen, to reach the ability to bear of back self to various feelings will aspect that heal.
Medicine of the present invention is used for the treatment of various livers, gallbladder, splenic disease, especially gallbladder disease is had specially good effect, can treat cholecystitis, gallbladder wall thickening, intercostal neuralgia, both sides of the chest overflow etc. effectively, and acute pancreatitis is also had better curative effect.
Prove that through clinical patients 200 routine applicable cases take medicine of the present invention, (when medicine part dosage was unit with the gram, the medicine of preparation can be made into potion after the course of treatment.General one day potion, four doses of courses of treatment), remission, pain disappearance person 158 examples, four during to twelve formulas of Chinese materia medica, is diagnosed as reference with B ultrasonic, the symptom complete obiteration, the focus cured person amounts to 198 examples, wherein, and because of other reason has two routine therapy discontinued, total effective rate 100%, cure rate is more than 98%, and follows up a case by regular visits to, and relapse rate is low.Sum up patient's medicining condition, pain can be alleviated rapidly, and the property of medicine is reliable, except that slight diarrhoea is arranged, does not have other untoward reaction, and especially after the medication, patient's appetite obviously increases, and complexion takes a turn for the better, and body constitution obviously strengthens.
Pharmaceutical purity Chinese medicine medicine part of the present invention is formed and investigated, and is scientific and reasonable, has no side effect, take simple and conveniently, therapeutic effect is good, and curative effect is fast, efficacy stability, treatment liver, gallbladder, splenic disease are reliable and stable, and relapse rate is low, and can improve autoimmunity more afterwards, especially to treating gallbladder disease specially good effect is arranged.
Several routine clinical application cases are as follows:
Case 1, Linzi District, Zibo City Mrs Ding, at 47 years old age, its cholecystitis has 15 years medical histories, in May nineteen ninety-five concurrent hepatosplenomegaly, atrophy of gallbladder, facial blackout, Huang, general weakness, anorexia is detested greasy, be diagnosed as atrophy of gallbladder through various big hospital expert inspection, concurrent hep of later stage becomes, and is diagnosed as gallbladder and can not absorbs the drug, and the suggestion immediate surgery excises one's gallbladder.In operation the first seven day, the patient is to my clinic, use four doses of medicines of the present invention after, the state of an illness has had and has been clearly better, take twelve formulas of Chinese materia medica continuously after, in the 15 day through the Zibo City hot shop central hospital expert diagnosis, color ultrasound examination patient, gallbladder returns to one's perfect health, and morphological function is all normal, liver, each transference cure of spleen, diet is normal, and after curing certainly, housework and other physical work are with competent fully, follow up a case by regular visits to, so far not recurrence.
Case 2, the Suo Zhen of the Zibo City Wang of Highway Administration Bureau found when having a medical check-up in 1994, liver-gallbladder disease (hepatitis B, cholecystitis), and through moving in district hospital's treatment, surplus in the of 60 do not heal in the sky.After use Drug therapy of the present invention instead, potion on the one, behind the twelve formulas of Chinese materia medica, diet, liver and gall index are all normal, after patient's rehabilitation, can work again.
Case 3, pharmaceutical factory one workman of Zibo City's Zhangdian District Xinhua honest and just certain, in 1998, discoverys of having a medical check-up, cholecystitis, hepatosplenomegaly, the facial jaundice do not thought appetite, myasthenia of limbs.Have no resolution through hospitalize in many ways.After use Drug therapy of the present invention, after 2 courses of treatment, patient is clearly better, and patient's treatment confidence has strengthened.Through the treatment of a course of treatment, the patient returns to one's perfect health again, so far not recurrence.
The specific embodiment
The present invention is further illustrated below in conjunction with embodiment.
Embodiment 1, treatment liver of the present invention, gallbladder, splenic disease medicine, form by following active component:
The Radix Paeoniae Alba 120 grams, Radix Bupleuri 5 grams, Radix Glycyrrhizae 50 grams, Olibanum 5 grams, the Radix Aucklandiae 5 grams, Semen Sinapis Albae 30 grams, Semen Persicae 8 grams, the Radix Rehmanniae 60 grams, Fructus Aurantii 5 grams, Radix Angelicae Sinensis 50 grams, Rhizoma Chuanxiong 3 grams, Fructus Gardeniae 10 grams, the Radix Astragali 50 grams, Radix Codonopsis 15 grams.
Buy each component medical material, mix the back and make oral liquid according to the conventional method decocting.
Embodiment 2, treatment liver of the present invention, gallbladder, splenic disease medicine, form by following active component:
The Radix Paeoniae Alba 130 grams, Radix Bupleuri 6 grams, Radix Glycyrrhizae 45 grams, Olibanum 6 grams, the Radix Aucklandiae 5 grams, Semen Sinapis Albae 35 grams, Semen Persicae 7 grams, the Radix Rehmanniae 60 grams, Fructus Aurantii 4 grams, Radix Angelicae Sinensis 55 grams, Rhizoma Chuanxiong 5 grams, Fructus Gardeniae 8 grams, the Radix Astragali 40 grams, Radix Codonopsis 20 grams.
Decocting becomes oral liquid.
Embodiment 3, treatment liver of the present invention, gallbladder, splenic disease medicine, form by following active component:
The Radix Paeoniae Alba 115 grams, Radix Bupleuri 5 grams, Radix Glycyrrhizae 50 grams, Olibanum 4 grams, the Radix Aucklandiae 6 grams, Semen Sinapis Albae 40 grams, Semen Persicae 8 grams, the Radix Rehmanniae 50 grams, Fructus Aurantii 4 grams, Radix Angelicae Sinensis 45 grams, Rhizoma Chuanxiong 3 grams, Fructus Gardeniae 9 grams, the Radix Astragali 55 grams, Radix Codonopsis 12 grams.
Decocting becomes oral liquid.
Embodiment 4, treatment liver of the present invention, gallbladder, splenic disease medicine, form by following active component:
The Radix Paeoniae Alba 135 grams, Radix Bupleuri 7 grams, Radix Glycyrrhizae 45 grams, Olibanum 6 grams, the Radix Aucklandiae 5 grams, Semen Sinapis Albae 40 grams, Semen Persicae 8 grams, the Radix Rehmanniae 60 grams, Fructus Aurantii 5 grams, Radix Angelicae Sinensis 48 grams, Rhizoma Chuanxiong 4 grams, Fructus Gardeniae 10 grams, the Radix Astragali 56 grams, Radix Codonopsis 16 grams.
Decocting becomes oral liquid.
Embodiment 5, treatment liver of the present invention, gallbladder, splenic disease medicine, form by following active component:
The Radix Paeoniae Alba 130 grams, Radix Bupleuri 7 grams, Radix Glycyrrhizae 50 grams, Olibanum 6 grams, the Radix Aucklandiae 7 grams, Semen Sinapis Albae 35 grams, Semen Persicae 9 grams, the Radix Rehmanniae 60 grams, Fructus Aurantii 3 grams, Radix Angelicae Sinensis 40 grams, Rhizoma Chuanxiong 5 grams, Fructus Gardeniae 13 grams, the Radix Astragali 53 grams, Radix Codonopsis 14 grams.
Make the watered pill, honeyed pill after refining the purification.
Embodiment 6, treatment liver of the present invention, gallbladder, splenic disease medicine, form by following active component:
The Radix Paeoniae Alba 140 grams, Radix Bupleuri 5 grams, Radix Glycyrrhizae 50 grams, Olibanum 5 grams, the Radix Aucklandiae 5 grams, Semen Sinapis Albae 40 grams, Semen Persicae 8 grams, the Radix Rehmanniae 50 grams, Fructus Aurantii 4 grams, Radix Angelicae Sinensis 50 grams, Rhizoma Chuanxiong 4 grams, Fructus Gardeniae 12 grams, the Radix Astragali 60 grams, Radix Codonopsis 14 grams.
Make the watered pill, honeyed pill after refining the purification.
Embodiment 7, treatment liver of the present invention, gallbladder, splenic disease medicine, form by following active component:
The Radix Paeoniae Alba 130 grams, Radix Bupleuri 6 grams, Radix Glycyrrhizae 55 grams, Olibanum 5 grams, the Radix Aucklandiae 6 grams, Semen Sinapis Albae 50 grams, Semen Persicae 8 grams, the Radix Rehmanniae 70 grams, Fructus Aurantii 5 grams, Radix Angelicae Sinensis 50 grams, Rhizoma Chuanxiong 4 grams, Fructus Gardeniae 15 grams, the Radix Astragali 45 grams, Radix Codonopsis 16 grams.
Make powder after refining the purification.
Claims (3)
1, a kind of medicine for the treatment of liver, gallbladder, splenic disease is characterized in that being made up of by weight following active component:
100～150 parts of the Radix Paeoniae Albas, 3～10 parts of Radix Bupleuri, 30～50 parts in Radix Glycyrrhizae, 3～10 parts of Olibanums, 3～10 parts of the Radix Aucklandiae, 15～60 parts of Semen Sinapis Albaes, 6～10 parts in Semen Persicae, 20～80 parts in the Radix Rehmanniae, 1～6 part of Fructus Aurantii, 10～80 parts of Radix Angelicae Sinensis, 1～6 part of Rhizoma Chuanxiong, 5～15 parts of Fructus Gardeniaes, 30～80 parts of the Radixs Astragali, 10～20 parts of Radix Codonopsis.
2, the medicine of treatment liver according to claim 1, gallbladder, splenic disease is characterized in that being made up of by weight following active component:
110～140 parts of the Radix Paeoniae Albas, 4～8 parts of Radix Bupleuri, 40～50 parts in Radix Glycyrrhizae, 4～8 parts of Olibanums, 4～8 parts of the Radix Aucklandiae, 25～45 parts of Semen Sinapis Albaes, 6～10 parts in Semen Persicae, 40～70 parts in the Radix Rehmanniae, 3～6 parts of Fructus Aurantiis, 40～60 parts of Radix Angelicae Sinensis, 2～5 parts of Rhizoma Chuanxiongs, 8～12 parts of Fructus Gardeniaes, 40～70 parts of the Radixs Astragali, 10～20 parts of Radix Codonopsis.
3, the medicine of treatment liver according to claim 1 and 2, gallbladder, splenic disease is characterized in that being made up of by weight following active component:
120 parts of the Radix Paeoniae Albas, 5 parts of Radix Bupleuri, 50 parts in Radix Glycyrrhizae, 5 parts of Olibanums, 5 parts of the Radix Aucklandiae, 30 parts of Semen Sinapis Albaes, 8 parts in Semen Persicae, 60 parts in the Radix Rehmanniae, 5 parts of Fructus Aurantiis, 50 parts of Radix Angelicae Sinensis, 3 parts of Rhizoma Chuanxiongs, 10 parts of Fructus Gardeniaes, 50 parts of the Radixs Astragali, 15 parts of Radix Codonopsis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02110418 CN1238001C (en) | 2002-05-23 | 2002-05-23 | Medicine for treating diseases of liver, gallbladder and spleen |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02110418 CN1238001C (en) | 2002-05-23 | 2002-05-23 | Medicine for treating diseases of liver, gallbladder and spleen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1383858A CN1383858A (en) | 2002-12-11 |
| CN1238001C true CN1238001C (en) | 2006-01-25 |
Family
ID=4741077
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 02110418 Expired - Fee Related CN1238001C (en) | 2002-05-23 | 2002-05-23 | Medicine for treating diseases of liver, gallbladder and spleen |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1238001C (en) |
-
2002
- 2002-05-23 CN CN 02110418 patent/CN1238001C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1383858A (en) | 2002-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101066303A (en) | Medicine for treating cerebral thrombus, cerebral angiosclerosis, apoplexy and hemiplegia and its prepn | |
| CN1899598A (en) | Combined medicine for preventing and treating rheumatism, rheumatoid, protrusion of intervertebral disc and hyperosteogeny | |
| CN1554413A (en) | Chinese medicine for treating urolithiasis and its preparing method | |
| CN1129130A (en) | Medicament for treatment of cervical spondylopathy | |
| CN102872301A (en) | Anti-rheumatism medicinal liquor and using method thereof | |
| CN1238001C (en) | Medicine for treating diseases of liver, gallbladder and spleen | |
| CN100579544C (en) | Chinese medicament preparation for treating cholecystitis and gall-stone as well as preparation method thereof | |
| CN1059559C (en) | Oral medicine and external-use medicine for curing osteonosus and processing method thereof | |
| CN1133458C (en) | Chinese herb medicine preparation for curing prolapse of lumbar intervertebral disk | |
| CN1418693A (en) | Oral liquid medicine for treating stomach-pain, and its prepn. method | |
| CN1084630C (en) | Mastopathy treating ointment | |
| CN1186044C (en) | Chinese medicine 'lidandishi' for treating hepatobiliary calculus and cholecystitis | |
| CN1053832C (en) | Chinese patent drug for cirrhosis of liver | |
| CN1435223A (en) | Externally applied medicinal stasis-and swelling-eliminating powder for treating chronic pelvic inflammation | |
| CN1709477A (en) | Chinese medicine formulation for treating ance disease | |
| CN1232281C (en) | Chinese medicine for treating osteoporosis and its preparation method | |
| CN1175875C (en) | Medicine made of lysimachia for treating hepatobiliary calculus and its prescription | |
| CN1284579C (en) | Oral medicine for treating ischemic necrosis of femoral head and its preparation | |
| CN1269520C (en) | Medicine for treating human lithic disease | |
| CN1090502C (en) | External use tradtional Chinese Medicine for treating hyperosteogeny, prolapse of lumbar intervertebral disc and various soft tissue injuries | |
| CN1203804A (en) | Ganbingkang medicine for curing liver disease | |
| CN1229126C (en) | Chinese medicine for curing rheumatoid arthritis | |
| CN102085350A (en) | Medicament for treating arthritis and preparation method thereof | |
| CN1380082A (en) | Chinese medicine for curing female chronic inflammation | |
| CN1255179C (en) | Medicine of cleanness without fleckiness and ringworm |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |